ISRCTN50847630已完成不适用
A comparison of the effects of rosiglitazone on endothelial function and arterial stiffness in insulin resistant individuals and normal controls
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 个研究点目标入组 36 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Not provided at time of registration
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Effect of rosiglitazone, compared to sulphonylurea, on endothelial function in Chinese patients with type two diabetesType two diabetesNutritional, Metabolic, EndocrineDiabetes mellitusISRCTN05215453Hong Kong University Research Committee (Hong Kong)68
已完成
不适用
Does treatment with rosiglitazone result in improved pancreatic beta-cell function as compared to glimepiride in metformin treated diabetes type 2 patients?Diabetes mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetes mellitusISRCTN52245496Academic Medical Centre (AMC) (The Netherlands)22
进行中（未招募）
不适用
Anti-inflammatory effects of rosiglitazone in patients with stage 4 and 5 chronic kidney disease - HerculesChronic kidney diseaseEUCTR2006-003001-49-NLeiden University Medical Center200
已完成
3 期
Anti-inflammatory effects of rosiglitazone in patients with stage 4 and 5 chronic kidney diseaseinflammation1001842410038430chronic kidney diseaseNL-OMON29938Academisch Medisch Centrum200
招募中
3 期
Comparison of pioglitazone and linagliptiIRCT20170513033941N66Kashan University of Medical Sciences60